Click a link below to view the mailing archive as if it had been sent to you.
| 2015-08-31 12:15 | | Can Baxalta hold off Shire with its own bid for Ariad? and more... |
| 2015-08-31 00:15 | | 5 Big FDA Decisions Expected in September and more... |
| 2015-08-30 12:15 | | Janssen Pharmaceuticals Accused of Hiding Risperdal's Breast Effects In Boys and more... |
| 2015-08-29 12:15 | | Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool and more... |
| 2015-08-29 00:15 | | Baxalta Said in Talks to Buy Ariad to Boost Cancer Offerings and more... |
| 2015-08-28 12:15 | | Bayer opens Costa Rica plant for Essure device and more... |
| 2015-08-28 00:15 | | FDA approves Amgen's cholesterol drug Repatha and more... |
| 2015-08-27 12:15 | | Pfizer plots Ibrance expansion as early-stage breast cancer trial begins and more... |
| 2015-08-27 00:15 | | Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion and more... |
| 2015-08-26 12:15 | | White House urged to stop states' 'rationing' of hep C drugs and more... |
| 2015-08-26 00:15 | | Mylan Fires Back at Perrigo and more... |
| 2015-08-25 12:15 | | Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device and more... |
| 2015-08-25 00:15 | | Biotech, pharma stocks take a beating as Dow plunges more than 580 points and more... |
| 2015-08-24 12:15 | | Pharma junkets for U.K. docs trigger tough new Sunshine rules, penalties and more... |
| 2015-08-23 12:15 | | The 3 Most Disappointing Drug Launches of All Time and more... |
| 2015-08-22 12:15 | | BioMarin's Big Bet on Muscular Dystrophy Is Already Paying Off and more... |
| 2015-08-22 00:15 | | Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart and more... |
| 2015-08-21 12:15 | | Amgen: Waiting for Clarity on Generic Biotech and more... |
| 2015-08-21 00:15 | | The 2013 Merck-Pfizer Diabetes Deal Now Looks Very Savvy and more... |
| 2015-08-20 12:15 | | AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche and more... |
| 2015-08-20 00:15 | | ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet and more... |
| 2015-08-19 12:15 | | Will pricey new drug classes take the wind out of diabetes launches? and more... |
| 2015-08-19 00:15 | | Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial and more... |
| 2015-08-18 12:15 | | 4 Top Pharma Stocks That Should Outperform Out To 2016 and more... |
| 2015-08-18 00:15 | | AbbVie Challenges Fairness Of Upcoming Testosterone Trials and more... |
| 2015-08-17 12:15 | | Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds and more... |
| 2015-08-16 12:15 | | The 5 Most Expensive Drugs in the World in 2015 and more... |
| 2015-08-16 00:15 | | Proxy adviser ISS slams Mylan's Perrigo bid, flagging 'unreasonable uncertainties' |
| 2015-08-15 12:15 | | BioDelivery: All Eyes On Belbuca and more... |
| 2015-08-14 12:15 | | J&J's Quarterly Results Not Reflective Of Underlying Strength and more... |
| 2015-08-14 00:15 | | Appeals court tosses $25M Accutane verdict against Roche and more... |
| 2015-08-13 12:15 | | Horizon stands by Depomed proposal, but company prepared to revise offer to include cash and more... |
| 2015-08-13 00:15 | | AbbVie Inc Cancer Drug Holds Blockbuster Potential and more... |
| 2015-08-12 12:15 | | How Bioinformatics Could Find The Next Breakthrough Cancer Drug and more... |
| 2015-08-12 00:15 | | Pfizer to cover NHS docs' script-switching costs in latest Lyrica-protecting move and more... |
| 2015-08-11 12:15 | | Shire PLC (ADR) - Baxalta Inc Merger Talk, What Will Be Shire’s Next Move? and more... |
| 2015-08-11 00:15 | | GSK defends low-margin strategy with a gloomy outlook for high drug prices and more... |
| 2015-08-10 12:15 | | GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain and more... |
| 2015-08-09 12:15 | | Did Gilead Sciences Just Give Wall Street a Huge Head Fake? |
| 2015-08-09 00:15 | | Will Horizon Boost its Bid for DepoMed? and more... |
| 2015-08-08 00:15 | | Bluebird Falls as Operating Costs Soar Amid Biotech Selloff and more... |
| 2015-08-07 12:15 | | AstraZeneca plc (ADR) Strikes 2 Immuno-Oncology Deals; Are Its Efforts In The Right Direction? and more... |
| 2015-08-07 00:15 | | Mylan CEO says does not 'have to' buy Perrigo, has other options and more... |
| 2015-08-06 12:15 | | IBM to buy Merge Healthcare in $1 billion deal and more... |
| 2015-08-06 00:15 | | Perrigo CEO says no easy path for Mylan to acquire company and more... |
| 2015-08-05 12:15 | | These 2 Catalysts Helped Push Celgene's Market Value Over $100 Billion in July and more... |
| 2015-08-05 00:15 | | Drug sales expected to top $1.3T in 2018 and more... |
| 2015-08-04 12:15 | | Celgene’s Bid for Receptos Could Be Topped and more... |
| 2015-08-04 00:15 | | How Tokai Pharmaceuticals is using precision medicine for prostate cancer and more... |
| 2015-08-03 12:15 | | Horizon asks for Depomed vote, files lawsuit in hostile bid and more... |
| 2015-08-02 12:15 | | The Blockbuster Potential of Biogen Inc's Pipeline and more... |
| 2015-08-01 12:15 | | Roche drug maker probed in Romanian graft case and more... |
| 2015-08-01 00:15 | | CEO Bradway, and markets, like the way Amgen's 'new product story' is shaping up and more... |
